Primo Chemicals Limited AI Stock Analysis
Want to see IN:PRIMO full AI Analyst Report?
Primo Chemicals Limited (PRIMO) AI Stock Analysis
Primo Chemicals Limited
(NSE:PRIMO)
The overall score is constrained by weak operating performance and a high valuation. While the balance sheet is healthy and technical trends are strongly positive, flat revenue and declining operating margins present a significant risk to earnings sustainability. The lack of dividend yield and a P/E above 43 further reduce the score.
Primo Chemicals Limited (PRIMO) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 5.17B
- Dividend Yield
- ―
- Average Volume (3M)
- 38.46K
- Price to Earnings (P/E)
- 32.6
- Beta (1Y)
- 0.40
- Revenue Growth
- -2.70%
- EPS Growth
- -15.41%
- Country
- India
- Employees
- 365
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Primo Chemicals Limited Business Overview & Revenue Model
Company Description
Headquartered in Chandigarh, India, Primo Chemicals Limited, established in 1975, is actively involved in the production and distribution of various chemical compounds across the country. The company's extensive product line encompasses industrial st...
Primo Chemicals Limited Financial Statement Overview
Summary
Mixed financial health. The balance sheet is stable with reduced leverage (D/E 0.32), and free cash flow grew 35%. However, revenue is flat, operating margins declined sharply, and the net income surge is driven by non-operating items, raising sustainability concerns.
Income Statement
38NegativeBalance Sheet
68PositiveCash Flow
58Neutral| Breakdown | TTM | Mar 2025 | Mar 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 2.90B | 5.62B | 5.56B |
| Gross Profit | 1.07B | 1.05B | 995.93M |
| EBITDA | 481.37M | 682.87M | 833.64M |
| Net Income | 37.51M | 153.71M | 35.60M |
Balance Sheet | |||
| Total Assets | 7.34B | 6.92B | 7.41B |
| Cash, Cash Equivalents and Short-Term Investments | 138.79M | 107.08M | 82.46M |
| Total Debt | 1.62B | 1.31B | 1.69B |
| Total Liabilities | 3.35B | 2.86B | 3.50B |
| Stockholders Equity | 3.99B | 4.06B | 3.91B |
Cash Flow | |||
| Free Cash Flow | 164.50M | 327.29M | 242.82M |
| Operating Cash Flow | 504.21M | 587.45M | 644.34M |
| Investing Cash Flow | -303.76M | -194.76M | -446.55M |
| Financing Cash Flow | -194.10M | -384.17M | -90.29M |
Primo Chemicals Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:PRIMO, the sentiment is Negative. The current price of 21.18 is below the 20-day moving average (MA) of 22.70, below the 50-day MA of 23.28, and below the 200-day MA of 22.57, indicating a bearish trend. The MACD of -0.75 indicates Positive momentum. The RSI at 40.23 is Neutral, neither overbought nor oversold. The STOCH value of 45.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:PRIMO.
Primo Chemicals Limited Peers Comparison
Overall Rating
IN:INDOAMIN76Outperform
IN:VALIANTORG63Neutral
IN:PRIMO59Neutral
IN:DMCC53Neutral
IN:UNIENTER51Neutral
IN:DIAMINESQ43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | INR 8.49B | 10.50 | ― | 0.43% | 13.23% | 22.22% | |
| 63Neutral | INR 10.18B | 15.45 | ― | ― | 21.32% | 175.87% | |
| 59Neutral | INR 5.13B | 32.64 | ― | ― | -2.70% | -15.41% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | INR 6.18B | 16.46 | ― | 1.00% | 72.14% | 34.49% | |
| 51Neutral | INR 6.63B | 34.44 | ― | 3.65% | -68.82% | 1.74% | |
| 43Neutral | INR 2.34B | -28.20 | ― | 0.43% | -27.77% | -61.55% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:PRIMO | Primo Chemicals Limited | 21.18 | -1.43 | -6.32% | |
| IN:DIAMINESQ | Diamines & Chemicals Ltd. | 232.70 | -51.30 | -18.06% | |
| IN:DMCC | DMCC Speciality Chemicals Limited | 247.70 | -31.84 | -11.39% | |
| IN:INDOAMIN | Indo Amines Limited | 117.00 | -14.17 | -10.80% | |
| IN:UNIENTER | Uniphos Enterprises Limited | 95.35 | -54.14 | -36.21% | |
| IN:VALIANTORG | Valiant Organics Limited | 363.30 | 77.45 | 27.09% |
Primo Chemicals Limited Corporate Events
Primo Chemicals Publishes Unaudited Financial Results Advertisements
Primo Chemicals Limited operates in the chemicals industry; the release does not specify its primary products, services, or market focus.The company notified the exchanges that advertisements for its unaudited standalone and consolidated financial re...
Primo Chemicals Moves to Merge Flow Tech Subsidiary for Streamlined Growth
Primo Chemicals Limited’s board has approved a draft scheme of amalgamation to merge its wholly owned subsidiary, Flow Tech Chemicals Private Limited, into the parent company, effective from October 1, 2026, subject to corporate, regulatory and Natio...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 29, 2026
